LAWLOR SALLY BRIDGET (Chief Financial Officer) purchased 2328.2% of their position (10.24K shares) of QUOIN PHARMACEUTICALS, LTD. on the open market
Open‑market purchase worth $50.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/2/2026ACC: 0001104659-26-104403
Officer· Chief Financial Officer
Since Feb 2026
+15.37K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
15.37K acquired
Non-Derivative Transactions1
ADSs
Direct
Shares
+10.24K
Price / share
$4.88
Trade value
$49.99K
% of position
2328.2%
8/31/2026
440.00→10.68K
Total
Net shares
+10.24K
Net value
$49.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ADSs Direct | 8/31/2026 | P · Purchase | +10.24K | $4.88 | $49.99K | 2328.2% | 440.00 | 10.68K |
| Total | +10.24K | $49.99K | ||||||
Derivative Transactions1
Ordinary Warrants (Right to Buy)
Direct
Converts to
ADS
5.12K shares
Shares
+5.12K
Strike price
6.10
Held after
5.12K
Exercisable
—
8/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Ordinary Warrants (Right to Buy) Direct | ADS5.12K shares | 8/31/2026 | P · Purchase | +5.12K | 6.10 | — | 5.12K |